Age-related changes in A(1)-adenosine receptor-mediated bradycardia

Am J Physiol Heart Circ Physiol. 2000 Mar;278(3):H789-95. doi: 10.1152/ajpheart.2000.278.3.H789.

Abstract

The impact of age on functional sensitivity to A(1)-adenosine receptor activation was studied in Langendorff-perfused hearts from young (1-2 mo) and old (12-18 mo) male Wistar rats. Adenosine mediated bradycardia in young and old hearts, with sensitivity enhanced approximately 10-fold in old [negative logarithm of EC(50) (pEC(50)) = 4.56 +/- 0.11] versus young hearts (pEC(50) = 3.70 +/- 0. 09). Alternatively, the nonmetabolized A(1) agonists N(6)-cyclohexyladenosine and (R)-N(6)-phenylisopropyladenosine were equipotent in young (pEC(50) = 7.43 +/- 0.12 and 6.61 +/- 0.19, respectively) and old hearts (pEC(50) = 7.07 +/- 0.10 and 6.80 +/- 0. 11, respectively), suggesting a role for uptake and/or catabolism in age-related changes in adenosine sensitivity. In support of this suggestion, [(3)H]-adenosine uptake was approximately twofold greater in young than in old hearts (from 3-100 microM adenosine). However, although inhibition of adenosine deaminase and adenosine transport with 10 microM erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride and 10 microM S-(4-nitrobenzyl)-6-thioinosine increased adenosine sensitivity three- to fourfold, it failed to abolish the sensitivity difference in old (pEC(50) = 4.95 +/- 0.08) versus young (pEC(50) = 4.29 +/- 0.13) hearts. Data indicate that 1) age increases functional A(1) receptor sensitivity to adenosine without altering the sensitivity of the A(1) receptor itself, and 2) age impairs adenosine transport and/or catabolism, but this does not explain differing functional sensitivity to adenosine. This increased functional sensitivity to adenosine may have physiological significance in the older heart.

MeSH terms

  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Adenosine / analogs & derivatives
  • Adenosine / metabolism
  • Adenosine / pharmacology*
  • Adenosine Deaminase Inhibitors
  • Aging*
  • Animals
  • Bradycardia / etiology*
  • Bradycardia / physiopathology
  • Enzyme Inhibitors / pharmacology
  • Male
  • Rats
  • Rats, Wistar
  • Receptors, Purinergic P1 / drug effects
  • Receptors, Purinergic P1 / physiology*
  • Tritium

Substances

  • Adenosine Deaminase Inhibitors
  • Enzyme Inhibitors
  • Receptors, Purinergic P1
  • Tritium
  • N-(1-methyl-2-phenylethyl)adenosine
  • 9-(2-hydroxy-3-nonyl)adenine
  • Adenine
  • Adenosine